These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 11843690)

  • 1. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
    Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
    Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Risk Factors for Refractory Status Epilepticus.
    Tatro HA; Hamilton LA; Peters C; Rowe AS
    Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children.
    Peariso K; Arya R; Glauser T; Abend NS; Barcia Aguilar C; Amengual-Gual M; Anderson A; Appavu BL; Brenton JN; Carpenter J; Chapman KE; Clark J; Gaillard WD; Gaínza-Lein M; Goldstein J; Goodkin H; Grinspan Z; Guerriero RM; Horn PS; Huh L; Kahoud R; Kelley SA; Kossoff EH; Kapur K; Lai YC; Marquis BO; McDonough T; Mikati MA; Morgan L; Novotny E; Ostendorf AP; Payne ET; Piantino J; Riviello J; Sands T; Stafstrom CE; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2023 Aug; 101(5):e546-e557. PubMed ID: 37295955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
    Mitchell WG
    Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
    Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
    Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
    Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
    Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
    Reddy DS
    J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of outcome in refractory status epilepticus.
    Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
    JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.
    Kantanen AM; Sairanen J; Kälviäinen R
    Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very high dose phenobarbital for refractory status epilepticus.
    Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
    J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.